CAPECITABINE 500 MG TABLET
For 30 tablets
Pharmacies pay
$13.67 filed
30 × $0.45556 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part B pays
$8.70 derived
30 × $0.29 per EA, Part B limit
Medicare's price is not your price.
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
The spread
0.64× estimated
Medicare pays 36% less than pharmacies pay.
13 labelers share HCPCS J8522 on the CMS crosswalk, so its payment limit is an average across all their products billed under that code, not this NDC’s own price.
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Cost-plus estimate
$20.72 estimated
$13.67 + $2.05 (15%) + $5.00 fee per fill = $20.72
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
CAPECITABINE 500 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as capecitabine.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 14 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Accord Healthcare Inc. and Camber Pharmaceuticals, Inc.
FDA’s Established Pharmacologic Class for it is Nucleoside Metabolic Inhibitor.
The NADAC file of 2026-10-14 prices it under 17 NDCs (National Drug Codes); the FDA directory lists 15 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $13.67 for 30 tablets (30 × $0.45556 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 14 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Camber Pharmaceuticals, Inc. | 2 | $0.45556 per EA filed |
| Accord Healthcare Inc. | 1 | $0.45556 per EA filed |
| American Health Packaging | 1 | $0.45556 per EA filed |
| Ascend Laboratories, LLC | 1 | $0.45556 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.45556 per EA filed |
| BluePoint Laboratories | 1 | $0.45556 per EA filed |
| Cipla USA Inc. | 1 | $0.45556 per EA filed |
| CivicaScript LLC | 1 | $0.45556 per EA filed |
| Dr. Reddy's Laboratories Limited | 1 | $0.45556 per EA filed |
| Lifestar Pharma LLC | 1 | $0.45556 per EA filed |
| NorthStar RxLLC | 1 | $0.45556 per EA filed |
| Novadoz Pharmaceuticals LLC | 1 | $0.45556 per EA filed |
| Quallent Pharmaceuticals Health LLC | 1 | $0.45556 per EA filed |
| Teva Pharmaceuticals USA, Inc. | 1 | $0.45556 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.45556 per EA filed |
All 17 NDCs, with labeler and price
- 00093-7474-89 · Teva Pharmaceuticals USA, Inc. · $0.45556 per EA · eff. 2026-09-23 filed
- 16729-0073-29 · Accord Healthcare Inc. · $0.45556 per EA · eff. 2026-09-23 filed
- 31722-0775-12 · Camber Pharmaceuticals, Inc. · $0.45556 per EA · eff. 2026-09-23 filed
- 31722-0775-60 · Camber Pharmaceuticals, Inc. · $0.45556 per EA · eff. 2026-09-23 filed
- 55111-0497-04 · Dr. Reddy's Laboratories Limited · $0.45556 per EA · eff. 2026-09-23 filed
- 59651-0205-08 · Aurobindo Pharma Limited · $0.45556 per EA · eff. 2026-09-23 filed
- 60687-0149-11 · not listed as a package in the FDA directory · $0.45556 per EA · eff. 2026-09-23 filed
- 60687-0149-94 · American Health Packaging · $0.45556 per EA · eff. 2026-09-23 filed
- 62135-0784-12 · not listed as a package in the FDA directory · $0.45556 per EA · eff. 2026-09-23 filed
- 67877-0459-12 · Ascend Laboratories, LLC · $0.45556 per EA · eff. 2026-09-23 filed
- 68001-0644-07 · BluePoint Laboratories · $0.45556 per EA · eff. 2026-09-23 filed
- 69097-0948-08 · Cipla USA Inc. · $0.45556 per EA · eff. 2026-09-23 filed
- 70756-0816-22 · Lifestar Pharma LLC · $0.45556 per EA · eff. 2026-09-23 filed
- 72205-0007-92 · Novadoz Pharmaceuticals LLC · $0.45556 per EA · eff. 2026-09-23 filed
- 72603-0303-01 · NorthStar RxLLC · $0.45556 per EA · eff. 2026-09-23 filed
- 82009-0112-12 · Quallent Pharmaceuticals Health LLC · $0.45556 per EA · eff. 2026-09-23 filed
- 82249-0210-12 · CivicaScript LLC · $0.45556 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
1 other product in the NADAC file shares the FDA nonproprietary name capecitabine with CAPECITABINE 500 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| CAPECITABINE 150 MG TABLET | $0.36154 per EA filed | $0.087 per EA derived |
| CAPECITABINE 500 MG TABLET this page | $0.45556 per EA filed | $0.29 per EA derived |
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
What Medicare paid
Medicare Part B’s payment limit for HCPCS J8522, for 2026-10-01 to 2026-12-31, comes to $8.70 for 30 tablets, or $0.29 per EA once converted to NADAC’s unit for this product.
Medicare Part B pays for this oral drug at a pharmacy only in specific circumstances CMS sets for this code; most prescriptions are paid by Part D.
The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.0058 per 50 MG.
11 of the product’s 17 NDCs have this Medicare figure; the other 6 do not, and the interactive card says why for each.
Medicare's price is not your price.
What the Part B payment limit is · Converting it to the NADAC unit · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part B: is this drug covered for me in this setting, and what is my share?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic class
Related in the same class
- MERCAPTOPURINE 50 MG TABLET
- TRIFLURIDINE 1% EYE DROPS
- FLUOROURACIL 0.5% CREAM
- FLUOROURACIL 2% TOPICAL SOLN